Coronavirus Update: Moderna’s COVID-19 Vaccine Passes First Test In Elderly Patients
Encouraging Results From Phase I Study
• By Scrip Team
The results show older people respond as well as younger individuals, generating antibodies 2-3 times higher than seen in convalescent sera 
